Lung Neuroendocrine Tumor — Trials

Lung Neuroendocrine Tumor — Trials · CancerIndex

Clinical trials

Registered studies

17 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02259725	Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors	completed	Phase 2	3	University of Southern CaliforniaOTHER	1	Dec 15, 2021	clinicaltrials
NCT00454363	Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer	completed	Phase 2	52	National Cancer Institute (NCI)NIH	1	Apr 3, 2020	clinicaltrials
NCT01010126	Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer	completed	Phase 2	252	National Cancer Institute (NCI)NIH	2	Jan 25, 2019	clinicaltrials
NCT00093782	Temsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma

Data updated 22 days agoSource updated Dec 15, 2021source: clinicaltrials